Clinical Trials Directory

Trials / Completed

CompletedNCT01869595

Thai MSM/TG Test and Treat Study

Prospective Study of Study to Evaluate the Feasibility of Universal HIV Testing and Antiretroviral Treatment Regardless of CD4 Count Using the Test and Treat Strategy Among Men Who Have Sex With Men and Transgender Women in Thailand

Status
Completed
Phase
Study type
Observational
Enrollment
600 (actual)
Sponsor
Thai Red Cross AIDS Research Centre · Academic / Other
Sex
Male
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

Objectives 1. To determine the uptake of universal HIV testing among Thai men who have sex with men (MSM) and transgender women (TG) 2. To determine the uptake of antiretroviral treatment (ART) regardless of CD4 count among Thai MSM/TG who test positive for HIV Subject population:. Men or transgender women who have sex with men,Thai nationals, age ≥18 years old, Have engaged in anal intercourse with a man without using a condom at least one time in the last 6 months or have had at least 3 male sex partners in the last 6 months,Not known to be HIV-positive (either have never been tested for HIV or have had a previous negative HIV test) Number of participants:2000 Thai MSM and TG with approximately 76%-90% in Bangkok, 5%-12% in Lampang and 5-12% in Ubonratchathani.

Detailed description

All participants will receive HIV testing at baseline. The frequency of study visits to determine HIV status in HIV-negative participants will be every 6 months for a total follow up time of 24 months. Once HIV-positive status is confirmed, participants will be offered ART immediately regardless of CD4 count. Those who accept ART will be seen more frequently following ART initiation, at 2 weeks, 4 weeks, 2 months, 3 months and every 3 months thereafter until completion of 24 months of follow-up. Those who deny immediate ART will have clinic visits every 6 months to monitor HIV disease. HIV-negative participants will be asked to come for HIV re-testing every 6 months or sooner if they feel exposed to risk

Conditions

Timeline

Start date
2012-11-01
Primary completion
2019-12-01
Completion
2020-11-01
First posted
2013-06-05
Last updated
2024-11-25

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01869595. Inclusion in this directory is not an endorsement.